Current Opinion in Infectious Diseases was launched in 1988. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of infectious diseases is divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Editors, and the Section Editors for this issue.
Roger G. Finch
Professor Roger Finch is Professor of Infectious Diseases at the University of Nottingham and Consultant Physician to the City Hospital, Nottingham and is Chairman of the NeLCD Advisory Committee. He graduated from the University of Birmingham and has held Postgraduate appointments at the Universities of Bristol and London and also in the United States.
Professor Finch has authored more than 320 papers covering the fields of antimicrobial chemotherapy, lower respiratory tract infections and the pathogenesis of staphylococcal disease. He is currently European Editor of Current Opinion in Infectious Diseases and was formerly Editor-in-Chief of the Journal of Antimicrobial Chemotherapy as well as serving on the editorial boards of several international Infection journals. He has published several books and is co-editor of the reference work Antibiotic and Chemotherapy (8th Edition).
Professor Finch was formerly Chairman of the Working Party on Clinical Evaluation of Antibacterial Drugs, member of the European Working Party on Clinical Trials of Anti-infective Agents and Co-Chairman of the Working Party on Self-medication of antibacterials without prescription. He was formerly President of the British Infection Society, Chairman of the Federation of Infection Societies and subsequently President of the European Society of Clinical Microbiology and Infectious Diseases. He serves on several committees of the UK Department of Health, including the Chair of the Advisory Committee on Antimicrobial Resistance & Healthcare Associated Infections. He is advisor to the European Commission and the Committee on Proprietary Medicinal Products.
Thomas F. Patterson
Dr Thomas Patterson received his BA degree from Baylor University, in Waco, Texas, and his MD from the University of Texas Medical School at Houston, Texas, USA. He completed his internship and residency at Vanderbilt University Medical School, in Nashville, Tennessee, and Yale-New Haven Hospital, and a fellowship in infectious diseases at Yale University School of Medicine, New Haven, Connecticut where he also served as an assistant professor of medicine.
Dr Patterson is currently Professor of Medicine in Infectious Diseases and Director of the Infectious Diseases Fellowship Training Program at the University of Texas Health Science Center in San Antonio, Texas. He is also Attending Physician at the South Texas Veterans Healthcare System, Audie Murphy Division, San Antonio, and Director of the San Antonio Center for Medical Mycology.
He has extensive experience in opportunistic fungal infections. His clinical and research interests focus on the diagnosis and treatment of fungal diseases, particularly in immunocompromised hosts. He has been involved in developing new antifungal drugs, and in clinical trials of new antifungal compounds.
Dr Patterson has published and lectured extensively on fungal infections. He is a member of the American Board of Internal Medicine Subspecialty on Infectious Diseases, and is co-Editor-in-Chief of the popular mycology website www.doctorfungus.org. He is a Fellow of the American College of Physicians, and also a past-president of the Texas Infectious Disease Society.
Dr Martin Fisher is Consultant Physician in HIV and Genitourinary Medicine at Brighton and Sussex University Hospitals and Honorary Senior Lecturer at Sussex University, Brighton, UK. After graduating from Guys Hospital, London University, he trained in HIV and Genitourinary Medicine at the Chelsea and Westminster and St Mary's Hospitals in London before taking up his current post in 1995. In addition to his clinical interests in outpatient and inpatient management of HIV infection, he leads an active research team with numerous ongoing studies including novel antiretroviral therapies and strategies, primary HIV infection, HIV/STI interactions, adherence to anti-HIV therapies, and novel strategies to improve detection of HIV and STIs. He is an active member of the British Association for Sexual Health and HIV (BASHH), Secretary to the British HIV Association (BHIVA), and is the Convenor of the Diploma in HIV Medicine.
Dr Anton Pozniak studied medicine at the University of Bristol and qualified as MBChB in 1979. He trained in genito-urinary medicine and HIV at the Middlesex Hospital, London, UK. He worked as a consultant physician in Zimbabwe where he researched for his doctorate in TB/HIV and moved back to the UK in 1991. He ran the HIV research unit at King's College, London before moving to his current position as Consultant Physician/Senior Lecturer at the Chelsea and Westminster Hospital in 1998. He became a fellow of the Royal College of Physicians in 1996.
Dr Pozniak is a life member of the British HIV Association (BHIVA), where he has helped to coordinate and write the BHIVA antiviral HIV guidelines, and is chair of the TB/HIV guidelines committee. He has served as an advisor on HIV and AIDS to the UK Government Health Select Committee. Dr Pozniak is a member of the UK Governments Expert Advisory Group on AIDS and on the executive of the European AIDS Clinical Society. He is on the Scientific Advisory Board of the charity LEPRA, and has been a trustee of the Terence Higgins Trust, the UK's largest HIV charity.
© 2008 Lippincott Williams & Wilkins, Inc.